Passive immunization of the human vagina

References

• Barnhart KT, Izquierdo A, Pretorius ES, Shera DM, Shabbout M, Shaunik A. Baseline dimensions of the human vagina. Hum Reprod. 2006 Jun;21(6):1–6. doi:https://doi.org/10.1093/humrep/del022.
   PubMedGoogle Scholar
• Pendergrass PB, Reeves CA, Belovicz MW. A technique for vaginal casting utilizing vinyl polysiloxane dental impression material. Gynecol Obstet Invest. 1991;32(2):121–22. doi:https://doi.org/10.1159/000293010.
   PubMed Web of Science ®Google Scholar
• Pendergrass PB, Reeves CA, Belovicz MW, Molter DJ, White JH. Comparison of vaginal shapes in Afro-American, caucasian and hispanic women as seen with vinyl polysiloxane casting. Gynecol Obstet Invest. 2000;50(1):54–59. doi:https://doi.org/10.1159/000010281.
   PubMed Web of Science ®Google Scholar
• Belec L, Meillet D, Levy M, Georges A, Tevi-Benissan C, Pillot J. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol. 1995 Jan;2(1):57–61. doi:https://doi.org/10.1128/cdli.2.1.57-61.1995.
   PubMedGoogle Scholar
• Mitchell C, Paul K, Agnew K, Gaussman R, Coombs RW, Hitti J. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol. 2011 Feb;49(2):735–36. doi:https://doi.org/10.1128/JCM.00991-10.
   PubMed Web of Science ®Google Scholar
• Pastor Z, Chmel R. Differential diagnostics of female “sexual” fluids: a narrative review. Int Urogynecol J. 2018 May;29(5):621–29. doi:https://doi.org/10.1007/s00192-017-3527-9.
   PubMed Web of Science ®Google Scholar
• WHO laboratory manual for the examination and processing of human semen. Geneva (Switzerland)o: World Health Organization; 2010.
   Google Scholar
• Li Z, Palaniyandi S, Zeng R, Tuo W, Roopenian DC, Zhu X. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proceedings of the National Academy of Sciences of the United States of America. 2011 Mar 15;108(11):4388–93. doi:https://doi.org/10.1073/pnas.1012861108.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Marathe J, Pudney J. The structure of the human vaginal stratum corneum and its role in immune defense. Am J Reprod Immunol. 2014 Jun;71(6):618–23. doi:https://doi.org/10.1111/aji.12230.
   PubMed Web of Science ®Google Scholar
• Gipson IK, Ho SB, Spurr-Michaud SJ, Tisdale AS, Zhan Q, Torlakovic E, Pudney J, Anderson DJ, Toribara NW, Hill JA, et al. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod. 1997 Apr;56(4):999–1011. doi:https://doi.org/10.1095/biolreprod56.4.999.
   PubMed Web of Science ®Google Scholar
• Gipson IK, Moccia R, Spurr-Michaud S, et al. The Amount of MUC5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metab. 2001 Feb;86(2):594–600.
   PubMed Web of Science ®Google Scholar
• Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD, Mahan AE, Karim MM, Licht AF, Zvonar I, et al. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunol. 2016 Mar 9;9(6):1549–58. doi:https://doi.org/10.1038/mi.2016.8.
   PubMed Web of Science ®Google Scholar
• Kremer J, Jager S. The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod. 1992 Jul;7(6):781–84. doi:https://doi.org/10.1093/oxfordjournals.humrep.a137737.
   PubMed Web of Science ®Google Scholar
• Schroeder HA, Nunn KL, Schaefer A, Henry CE, Lam F, Pauly MH, Whaley KJ, Zeitlin L, Humphrys MS, Ravel J, et al. Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition. Mucosal Immunol. 2018 Sep;11(5):1477–86. doi:https://doi.org/10.1038/s41385-018-0054-z.
   PubMed Web of Science ®Google Scholar
• Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol. 2020 Oct;20(10):633–43. doi:https://doi.org/10.1038/s41577-020-00410-0.
   PubMed Web of Science ®Google Scholar
• Sips M, Krykbaeva M, Diefenbach TJ, Ghebremichael M, Bowman BA, Dugast A-S, Boesch AW, Streeck H, Kwon DS, Ackerman ME, et al. Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies. Mucosal Immunol. 2016 Nov;9(6):1584–95. doi:https://doi.org/10.1038/mi.2016.12.
   PubMed Web of Science ®Google Scholar
• Cocklin SL, Schmitz JE. The role of Fc receptors in HIV infection and vaccine efficacy. Curr Opin HIV AIDS. 2014 May;9(3):257–62. doi:https://doi.org/10.1097/COH.0000000000000051.
   PubMed Web of Science ®Google Scholar
• Castle PE, Karp DA, Zeitlin L, Garcı́a-Moreno E B, Moench TR, Whaley KJ, Cone RA. Human monoclonal antibody stability and activity at vaginal pH. J Reprod Immunol. 2002 Jul-Aug;56(1–2):61–76. doi:https://doi.org/10.1016/S0165-0378(02)00013-X.
   PubMed Web of Science ®Google Scholar
• Bayigga L, Kateete DP, Anderson DJ, Sekikubo M, Nakanjako D. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention. Am J Obstet Gynecol. 2019 Feb;220(2):155–66. doi:https://doi.org/10.1016/j.ajog.2018.10.014.
   PubMed Web of Science ®Google Scholar
• Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007 Nov;34(11):864–69. doi:https://doi.org/10.1097/OLQ.0b013e318074e565.
   PubMed Web of Science ®Google Scholar
• Hoang T, Toler E, DeLong K, Mafunda NA, Bloom SM, Zierden HC, Moench TR, Coleman JS, Hanes J, Kwon DS, et al. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis. PLoS Pathog. 2020 Jan;16(1):e1008236. doi:https://doi.org/10.1371/journal.ppat.1008236.
   PubMed Web of Science ®Google Scholar
• Wiggins R, Hicks SJ, Soothill PW, Millar MR, Corfield AP. Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract. Sex Transm Infect. 2001 Dec;77(6):402–08. doi:https://doi.org/10.1136/sti.77.6.402.
   PubMed Web of Science ®Google Scholar
• Rudicell RS, Kwon YD, Ko S-Y, Pegu A, Louder MK, Georgiev IS, Wu X, Zhu J, Boyington JC, Chen X, et al. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. Journal of Virology. 2014 Nov;88(21):12669–82. doi:https://doi.org/10.1128/JVI.02213-14.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yu J, Lanzi A, Yao X, Andrews CD, Tsai L, Gajjar MR, Sun M, Seaman MS, Padte NN, et al. Engineered bispecific antibodies with exquisite HIV-1-neutralizing activity. Cell. 2016 June 16;165(7):1621–31. doi:https://doi.org/10.1016/j.cell.2016.05.024.
   PubMed Web of Science ®Google Scholar
• Xu L, Pegu A, Rao E, Doria-Rose N, Beninga J, McKee K, Lord DM, Wei RR, Deng G, Louder M, et al. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques. Science (New York, N.Y.) 2017 Oct 6;358(6359):85–90. doi:https://doi.org/10.1126/science.aan8630.
   PubMed Web of Science ®Google Scholar
• Hessell AJ, Hangartner L, Hunter M, Havenith CEG, Beurskens FJ, Bakker JM, Lanigan CMS, Landucci G, Forthal DN, Parren PWHI, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007 September 6;449(7158):101–04. doi:https://doi.org/10.1038/nature06106.
   PubMed Web of Science ®Google Scholar
• Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, Bleeker WK, Parren PWHI, Marx PA, Burton DR. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nature Medicine. 2009 Aug;15(8):951–54. doi:https://doi.org/10.1038/nm.1974.
   PubMed Web of Science ®Google Scholar
• Ko S-Y, Pegu A, Rudicell RS, Yang Z-Y, Joyce MG, Chen X, Wang K, Bao S, Kraemer TD, Rath T, et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature. 2014 August 13;514(7524):642–45. doi:https://doi.org/10.1038/nature13612.
   PubMed Web of Science ®Google Scholar
• Moldt B, Shibata-Koyama M, Rakasz EG, Schultz N, Kanda Y, Dunlop DC, Finstad SL, Jin C, Landucci G, Alpert MD, et al. A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcgammaRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques. Journal of Virology. 2012 Jun;86(11):6189–96. doi:https://doi.org/10.1128/JVI.00491-12.
   PubMed Web of Science ®Google Scholar
• Bournazos S, Klein F, Pietzsch J, Seaman MS, Nussenzweig MC, Ravetch JV. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell. 2014 Sep 11;158(6):1243–53. doi:https://doi.org/10.1016/j.cell.2014.08.023.
   PubMed Web of Science ®Google Scholar
• Gaudinski MR, Coates EE, Houser KV, Chen GL, Yamshchikov G, Saunders JG, Holman LA, Gordon I, Plummer S, Hendel CS, et al. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: a Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 Jan;15(1):e1002493. doi:https://doi.org/10.1371/journal.pmed.1002493.
   PubMed Web of Science ®Google Scholar
• Gupta S, Gach JS, Becerra JC, Phan TB, Pudney J, Joseph SB, Landucci G, Supnet MJ, Ping L-H, et al. The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog. 2013;9(11):e1003776. doi:https://doi.org/10.1371/journal.ppat.1003776.
   PubMed Web of Science ®Google Scholar
• Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proceedings of the National Academy of Sciences of the United States of America. 2011 Aug 2;108(31):12669–74. doi:https://doi.org/10.1073/pnas.1108455108.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Politch JA, Zeitlin L, Hiatt A, KadaMoldoveanusia K, Mayer KH, Ruprecht RM, Villinger F, Whaley KJ. Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV. AIDS. 2017 Jul 17;31(11):1505–17. doi:https://doi.org/10.1097/QAD.0000000000001521.
   PubMed Web of Science ®Google Scholar
• Morris GC, Wiggins RC, Woodhall SC, Bland JM, Taylor CR, Jespers V, Vcelar BA, Lacey CJ. MABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicide. PloS One. 2014;9(12):e116153. doi:https://doi.org/10.1371/journal.pone.0116153.
   PubMed Web of Science ®Google Scholar
• Ma JK, Drossard J, Lewis D, Altmann F, Boyle J, Christou P, Cole T, Dale P, Van Dolleweerd CJ, Isitt V, et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnology Journal. 2015 Oct;13(8):1106–20. doi:https://doi.org/10.1111/pbi.12416.
   PubMed Web of Science ®Google Scholar
• Politch JA, Cu-Uvin S, Moench TR, Tashima KT, Marathe JG, Guthrie KM, Cabral H, Nyhuis T, Brennan M, Zeitlin L, et al. Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): a Phase I randomized trial. PLoS Med. 2021 Feb;18(2):e1003495. doi:https://doi.org/10.1371/journal.pmed.1003495.
   PubMed Web of Science ®Google Scholar
• Isojima S, Kameda K, Tsuji Y, Shigeta M, Ikeda Y, Koyama K. Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma. J Reprod Immunol. 1987 Jan;10(1):67–78. doi:https://doi.org/10.1016/0165-0378(87)90051-9.
   PubMed Web of Science ®Google Scholar
• Baldeon-Vaca G, Marathe JG, Politch JA, et al. Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women. EBioMedicine. 2021;69: 103478.
   Web of Science ®Google Scholar
• Franklin RD, Kutteh WH. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol. 1999 Mar;42(2):93–106. doi:https://doi.org/10.1016/S0165-0378(98)00086-2.
   PubMed Web of Science ®Google Scholar
• Bouvet JP, Belec L, Pires R, Pillot J. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun. 1994 Sep;62(9):3957–61. doi:https://doi.org/10.1128/iai.62.9.3957-3961.1994.
   PubMed Web of Science ®Google Scholar
• Seaton KE, Deal A, Han X, Li SS, Clayton A, Heptinstall J, Duerr A, Allen MA, Shen X, Sawant S, et al. Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. NPJ Vaccines. 2021 Apr 15;6(1):56. doi:https://doi.org/10.1038/s41541-021-00305-8.
   PubMed Web of Science ®Google Scholar
• Pattyn J, Van Keer S, Tjalma W, Matheeussen V, Van Damme P, Vorsters A. Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature. Papillomavirus Res. 2019 Dec;8:100185. doi:https://doi.org/10.1016/j.pvr.2019.100185.
   PubMed Web of Science ®Google Scholar
• Scherpenisse M, Mollers M, Schepp RM, Meijer CJLM, de Melker HE, Berbers GAM, van der Klis FRM. Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination. Hum Vaccin Immunother. 2013 Feb;9(2):314–21. doi:https://doi.org/10.4161/hv.22693.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Politch JA, Cone RA, Zeitlin L, Lai SK, Santangelo PJ, Moench TR, Whaley KJ. Engineering monoclonal antibody-based contraception and multipurpose prevention technologiesdagger. Biol Reprod. 2020 Aug 4;103(2):275–85. doi:https://doi.org/10.1093/biolre/ioaa096.
   PubMed Web of Science ®Google Scholar